Influenza / COVID-19 / RSV Webinar Series - Webinar 1

2024 Influenza Webinar

HPV Update Webinar 2024

25th Annual Scientific Meeting 2024

2024 Meningococcal Webinar

Panel discussion - Session 6: Respiratory Virus Vaccines: Today and Tomorrow's Outlook

New technology vaccines: Safety and efficacy - Prof Margie Danchin

COVID-19 vaccine effectiveness - A/Prof Bette Liu

SNOTWATCH: Ecological approaches to understanding the impact of respiratory viruses Prof Jim Buttery

Panel discussion - Session 5: Primary Care and Vaccination

Innovating vaccine delivery - Prof Nigel Stocks

Primary Care and Vaccination: A pharmacist perspective - Brenton Hart

Primary Care and Vaccination: A nurse perspective - Angela Newbound

Optimising vaccine uptake strategies and targeting high risk patients - Dr Lisa Beecham

Meningococcal B is a preventable disease - A parent's perspective

Meningococcal B is a preventable disease - Lachlan's Story

Panel discussion - Session 4: Zoster

Additional benefits of vaccination (dementia, depression etc) - A/Prof Michael Woodward

The economic and individual value of Shingrix vaccination - Prof Katie Flanagan

Epidemiology of Zoster in the vaccine age (and immunological advances) - Prof Tony Cunningham

Panel discussion - Session 3: Economics and Long-Term Implications of Vaccines

Pneumococcal conjugate vaccines in children - Dr Sanjay Jayasinghe

Adult pneumococcal vaccination - Prof Tony Korman

Respiratory Syncytial Virus (RSV) - A/Prof Anthony Newall

Recent pandemics and informed predictions - Prof Stanley Perlman

COVID-19 and Disease X - Prof Kanta Subbarao

The history and future of respiratory viral disease surveillance - Prof Allen Cheng

Influenza and COVID-19 effects of and on chronic diseases - A/Prof Kirsty Short

UK Primary Care response to COVID-19 - Prof Richard Hobbs

A WHO perspective on new vaccines with a focus on dengue - Prof Annelies Wilder-Smith